Qilu Pharmaceutical Co., Ltd.: all 211 studies

Page 1 of 3. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.

• QLC5508 vs. Investigator's Choice Chemotherapy in Advanced Extrapulmonary Neuroendocrine CarcinomaNot yet recruitingNCT07894211Phase 3
• A Study of QLS2401 Injection in Participants With Advanced Prostate CancerNot yet recruitingNCT07869888Phase 1
• A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of QLS2312 InjectionNot yet recruitingNCT07861581Phase 1
• Comparative Study of QL1209 and Perjeta® in Healthy Male ParticipantsNot yet recruitingNCT07861139Phase 1
• Pharmacokinetic (PK) Study of QL1203 and Vectibix® for the Treatment of RAS Wild-type Metastatic Colorectal CancerNot yet recruitingNCT07829588Phase 1
• QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous AdministrationNot yet recruitingNCT07817004Phase 1
• A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Small Cell Lung CancerNot yet recruitingNCT07802821Phase 3
• Phase I Study of QLS1510 Tablets in Healthy ParticipantsNot yet recruitingNCT07760077Phase 1
• A Study of QLS2404 Injection in Healthy Participants and Participants With Rheumatic Autoimmune DiseasesNot yet recruitingNCT07751315Phase 1
• The First in Human Study of QLS2319 in Healthy Subjects and Cancer CachexiaRecruitingNCT07735104Phase 1/2
• Phase II Clinical Study on the Efficacy and Safety of QLS7305 in Patients With Kidney Disease (Part A)Not yet recruitingNCT07730632Phase 2
• Phase II Study of QLC2519 in Pediatric Solid Tumor ParticipantsRecruitingNCT07724756Phase 2
• QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJRecruitingNCT07716449Phase 3
• QLF4113 in Participants With Metastatic Prostate CancerNot yet recruitingNCT07636707Phase 1
• QLC5508 in Participants With Metastatic Prostate CancerNot yet recruitingNCT07632690Phase 3
• To Evaluate the Efficacy and Safety of QL2401 in Patients With Metabolic Dysfunction-associated Steatohepatitis and Liver FibrosisNot yet recruitingNCT07620366Phase 2
• Phase I Study of QLC5508 in Advanced Solid Tumors: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug InteractionRecruitingNCT07620041Phase 1
• A Study to Evaluate the Efficacy and Safety of Monosialotetrahexosylganglioside Sodium Injection in Parkinson's Disease Participants With Motor FluctuationsNot yet recruitingNCT07585565Phase 2
• QLS4131 Combination Therapy in Malignant Plasma Cell NeoplasmsNot yet recruitingNCT07560449Phase 2
• This Study Aims to Evaluate the Efficacy and Safety of QLS1317 in Patients With MSI-H/dMMR Advanced Solid Tumors.Not yet recruitingNCT07552376Phase 1
• Study of QLS1410 in the Treatment of Primary Aldosteronism.Not yet recruitingNCT07550465Phase 2
• QLS1410 in Participants With Uncontrolled HypertensionEnrolling by invitationNCT07489612Phase 2
• A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's DiseaseNot yet recruitingNCT07489599Phase 1
• A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular DegenerationNot yet recruitingNCT07489586Phase 3
• Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 DiabetesNot yet recruitingNCT07487103Phase 3
• QLS5212 for Participants With Advanced Solid TumorsRecruitingNCT07467629Phase 1
• QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell CarcinomaRecruitingNCT07463573Phase 3
• Study of QLS5308 in Patients With Advanced Solid TumorsNot yet recruitingNCT07462442Phase 1
• Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric PatientsNot yet recruitingNCT07455006Phase 3
• QLS5132 Combination Therapy in Advanced Solid TumorsNot yet recruitingNCT07453394Phase 1/2
• QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)Not yet recruitingNCT07450378Phase 3
• QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed DyslipidemiaNot yet recruitingNCT07444086Phase 3
• QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)Not yet recruitingNCT07441317Phase 3
• QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis SuppurativaNot yet recruitingNCT07417917Phase 2
• A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male SubjectsNot yet recruitingNCT07400744Phase 1
• QLS12010 in Participants With Moderate-to-severe Rheumatoid ArthritisNot yet recruitingNCT07377773Phase 2
• First in Human Study of QLS5316 in Solid TumorsNot yet recruitingNCT07358884Phase 1
• A Food Effect Study of QLS1410 in Healthy Chinese AdultsNot yet recruitingNCT07358858Phase 1
• A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic AnemiaNot yet recruitingNCT07345000Phase 3
• A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic DermatitisNot yet recruitingNCT07344051Phase 2
• A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy SubjectsNot yet recruitingNCT07327697Phase 1
• A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABPRecruitingNCT07327619Phase 3
• A Phase I Trial of Subcutaneous QLS7305 in Healthy AdultsNot yet recruitingNCT07313150Phase 1
• Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe AsthmaNot yet recruitingNCT07302516Phase 3
• A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)Not yet recruitingNCT07300111Phase 3
• A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological MalignanciesNot yet recruitingNCT07294300Phase 1
• Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid TumorsNot yet recruitingNCT07272590Phase 1/2
• A Study of QLC5508 Combinations in Patients With Advanced Solid TumorsRecruitingNCT07256782Phase 1/2
• Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer PatientsRecruitingNCT07235176Phase 1/2
• A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate CancerRecruitingNCT07198633Phase 1/2
• A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic MalignanciesRecruitingNCT07173595Phase 1
• A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast CancerNot yet recruitingNCT07173556Phase 1/2
• A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential HypertensionNot yet recruitingNCT07152444Phase 1
• Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract CancerNot yet recruitingNCT07151872Phase 2
• A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)Not yet recruitingNCT07138833Phase 4
• A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple MyelomaRecruitingNCT07138209Phase 3
• Assess the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Meropenem-Pralubactam (Meropenem/FL058) in China Healthy Adult ParticipantsRecruitingNCT07124468Phase 1
• Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate CancerNot yet recruitingNCT07104110Phase 1/2
• Study of MHB088C for Patients With Advanced Solid Malignant TumorsRecruitingNCT07102004Phase 1/2
• Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae InfectionsRecruitingNCT07089186Phase 3
• A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic CancerRecruitingNCT07079228Phase 3
• Pharmacokinetics and Pharmacodynamics StudyNot yet recruitingNCT07074236Phase 1
• A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®RecruitingNCT07062978Phase 3
• A Study of QLS5133 Monotherapy in Advanced Solid TumorsNot yet recruitingNCT07061639Phase 1/2
• QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal CancerNot yet recruitingNCT07025239Phase 3
• Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple MyelomaRecruitingNCT07018050Phase 2
• A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus ErythematosusNot yet recruitingNCT07001839Phase 1
• GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast CancerRecruitingNCT06994507Phase 3
• The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy SubjectsNot yet recruitingNCT06980909Phase 1
• A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung CancerRecruitingNCT06954246Phase 3
• A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Therapies in the Treatment of Patients With Advanced Solid Tumors Harboring a KRAS G12D MutationNot yet recruitingNCT06949761Phase 1/2
• A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis PatientsRecruitingNCT06946641Phase 1
• Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaNot yet recruitingNCT06942767Phase 2
• To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid PolyneuropathyRecruitingNCT06940336Phase 4
• Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid TumorsNot yet recruitingNCT06932094Phase 1
• A Study of QLM2011 in Subjects With Advanced Solid TumorsNot yet recruitingNCT06925659Phase 1
• A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor PatientsRecruitingNCT06911827Phase 1/2
• To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of FractureNot yet recruitingNCT06898060Phase 3
• A Phase Ⅲ Comparative Study of QL2108 to Dupixent®Not yet recruitingNCT06884891Phase 3
• Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic DermatitisRecruitingNCT06880276Phase 3
• A Study of QLS1209 in theTreatment of Patients With Advanced Solid TumorsNot yet recruitingNCT06872580Phase 1
• QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06852456Phase 2
• Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant TumorsRecruitingNCT06823609Phase 1
• a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy.Not yet recruitingNCT06789796Phase 3
• A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLCRecruitingNCT06754644Phase 3
• Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL CholesterolNot yet recruitingNCT06750341Phase 2
• To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple MyelomaNot yet recruitingNCT06742138Phase 3
• A Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast CancerRecruitingNCT06732323Phase 3
• A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon CancerRecruitingNCT06686576Phase 3
• Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsRecruitingNCT06671548Phase 3
• A Study of Olanzapine-Samidorphan Tablets in Adults With SchizophreniaNot yet recruitingNCT06649214Phase 3
• Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With IruplinalkibNot yet recruitingNCT06644495
• Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAINot yet recruitingNCT06633718Phase 3
• Compare the Efficacy and Safety of QL0605 Injections at Different TimepointsRecruitingNCT06616571Phase 4
• A Study of QLS4131 in Patients With Recurrent or Refractory Multiple MyelomaNot yet recruitingNCT06500507Phase 1
• QL0911 for the Treatment of Cancer Treatment-Induced ThrombocytopeniaRecruitingNCT06456528Phase 2/3
• Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid TumorsNot yet recruitingNCT06446388Phase 2
• Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe PruritusRecruitingNCT06446310Phase 3
• A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus NephritisRecruitingNCT06406205Phase 3
• A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid TumorsRecruitingNCT06403735Phase 1

← Qilu Pharmaceutical Co., Ltd. overview and focus areas